Important Considerations for Outsourcing Biomarker Assays, Upcoming Webinar Hosted by Xtalks

TORONTO, Oct. 29, 2020 /PRNewswire-PRWeb/ -- A lot has already been written about the difference between biomarker assays and PK assays. However, in our daily work in a CRO setting, we still find that many potential sponsors are struggling with the challenges specific to biomarker outsourcing. It is not easy to clearly define a biomarker's Context of Use (CoU) in a study or to get all the stakeholders involved in understanding the biology and use of the study data. It requires mutual understanding and close collaborations.

In this webinar, the speakers will explain why biomarker assay outsourcing is different and will describe good practices and how a pharmaceutical company and a CRO can efficiently collaborate in this process. PRA realizes that biomarker assays require special attention in order to provide reliable and useful data.

Join Radboud van Trigt, PhD, Director of Bioanalytical Science – Biomarkers, PRA Health Sciences and Amanda Hays, Ph.D., Director of Bioanalytical Science, PRA Health Sciences in a live webinar on Friday, November 13, 2020 at 10am EST (3pm GMT/UK) to gain insights from PRA about biomarker assay outsourcing.

For more information or to register for this event, visit Important Considerations for Outsourcing Biomarker Assays.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit
For information about hosting a webinar visit



Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.